Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.100
+0.060 (2.94%)
At close: Oct 24, 2024, 4:00 PM
2.090
-0.010 (-0.48%)
After-hours: Oct 24, 2024, 4:39 PM EDT
Cellectar Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Selling, General & Admin | 13.32 | 10.75 | 9.59 | 6.54 | 5.15 | 5.18 | |
Research & Development | 28.94 | 28.21 | 19.22 | 17.59 | 10.14 | 9 | |
Operating Expenses | 42.26 | 38.96 | 28.81 | 24.13 | 15.29 | 14.18 | |
Operating Income | -42.26 | -38.96 | -28.81 | -24.13 | -15.29 | -14.18 | |
Interest & Investment Income | 0.58 | 0.39 | 0.15 | 0 | 0.01 | 0.04 | |
Other Non Operating Income (Expenses) | -9.37 | 0.53 | - | 0.01 | - | 0.04 | |
EBT Excluding Unusual Items | -51.04 | -38.04 | -28.66 | -24.12 | -15.28 | -14.09 | |
Other Unusual Items | - | - | - | - | 0.19 | - | |
Pretax Income | -51.04 | -38.04 | -28.66 | -24.12 | -15.09 | -14.09 | |
Income Tax Expense | -0.06 | -0.06 | -0.06 | - | - | - | |
Net Income | -50.98 | -37.98 | -28.6 | -24.12 | -15.09 | -14.09 | |
Net Income to Common | -50.98 | -37.98 | -28.6 | -24.12 | -15.09 | -14.09 | |
Shares Outstanding (Basic) | 17 | 12 | 7 | 6 | 2 | 1 | |
Shares Outstanding (Diluted) | 17 | 12 | 7 | 6 | 2 | 1 | |
Shares Change (YoY) | 100.67% | 73.22% | 27.09% | 180.20% | 158.14% | 159.12% | |
EPS (Basic) | -3.05 | -3.11 | -4.05 | -4.35 | -7.62 | -18.36 | |
EPS (Diluted) | -3.05 | -3.11 | -4.05 | -4.35 | -7.62 | -18.36 | |
Free Cash Flow | -39.44 | -33.24 | -25.45 | -22.71 | -14 | -11.72 | |
Free Cash Flow Per Share | -2.36 | -2.72 | -3.61 | -4.09 | -7.06 | -15.27 | |
EBITDA | -42.02 | -38.77 | -28.67 | -23.98 | -15.15 | -14.05 | |
D&A For EBITDA | 0.24 | 0.19 | 0.15 | 0.15 | 0.14 | 0.13 | |
EBIT | -42.26 | -38.96 | -28.81 | -24.13 | -15.29 | -14.18 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.